Founder of @ReoLab • Worked @Lockheed Martin, @Stanford Research Systems • PhD Materials Science @University of Southern California
ReoLab is creating the first modern hardware language for biochemistry: discrete, miniaturized modules that can be rapidly assembled into reactors and instruments with arbitrary complexity and scalability. We aim to accelerate drug discovery by disrupting the $25B market segment for preclinical contract research. Pharma and biopharma customers send us their complex screening protocols, we send them back data – with game changing benefits to speed, reduced reagent use, precision, and flexibility.